Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-U.S. directs millions of COVID-19 shots to Latin America, Africa, Asia

Mon, 21st Jun 2021 17:33

(Adds comments from White House spokesperson)

By Jeff Mason

June 21 (Reuters) - The White House laid out a plan on
Monday to share 55 million U.S. COVID-19 vaccine doses globally,
with roughly 75% of the doses allocated to Latin America and the
Caribbean, Asia and Africa through the COVAX international
vaccine-sharing program.

The plan fulfills President Joe Biden's commitment to share
80 million U.S.-made vaccines with countries around the world.
The president sketched out his priorities for the first 25
million doses from that pledge earlier this month.

The United States has come under pressure to share more of
its vaccine supply with countries that are still struggling with
the deadly virus and its variants. With more and more Americans
getting the shots, the White House increasingly has turned its
attention to getting vaccine out internationally. (Graphic on
global vaccinations) https://tmsnrt.rs/3tUM8ta

Of the 55 million remaining doses, some 41 million will be
shared through COVAX, the White House said, with approximately
14 million going to Latin America and the Caribbean, some 16
million to Asia, and roughly 10 million to Africa.

The other 25%, or roughly 14 million doses, will be shared
with "regional priorities," including Colombia, Argentina, Iraq,
Ukraine, the West Bank and Gaza.

White House spokeswoman Jen Psaki said the United States had
faced logistical issues getting vaccine to other nations.

"We have plenty of doses to share with the world, but this
is a Herculean logistical challenge," she told reporters, noting
safety and regulatory information had to be shared, proper
storage temperatures for the vaccines had to be ensured, and
language barriers at times had to be overcome.

"We have announced today where these doses are going. We
will continue to announce as they land on the ground and as they
are being shipped, and we're looking forward to doing that as
quickly as possible," she said.

The 55 million doses will be taken from the U.S. supply of
Pfizer Inc, Moderna Inc, and Johnson & Johnson
shots, though if AstraZeneca's vaccine gets a
green light from the Food and Drug Administration, it would
likely be added to the mix as well.

The White House said it wanted the doses to be prioritized
for health care workers and those who are most at risk.

International partners are eager to get U.S. help. Biden has
announced the United States will buy 500 million doses of
Pfizer's vaccine and donate them to the world's poorest
countries.

The White House's breakdown of its allocation of the 55
million vaccine doses is below.

THROUGH COVAX:

* Latin America and the Caribbean (approximately 14 million
shots): Brazil, Argentina, Colombia, Peru, Ecuador, Paraguay,
Bolivia, Uruguay, Guatemala, El Salvador, Honduras, Haiti, and
other Caribbean Community (CARICOM) countries, Dominican
Republic, Panama, and Costa Rica

* Asia (approximately 16 million shots): India, Nepal,
Bangladesh, Pakistan, Sri Lanka, Afghanistan, Maldives, Bhutan,
Philippines, Vietnam, Indonesia, Thailand, Malaysia, Laos, Papua
New Guinea, Taiwan, Cambodia, and the Pacific Islands.

* Africa (approximately 10 million shots): Recipient
countries will be selected in coordination with the African
Union.

THROUGH DIRECT SHARING: Colombia, Argentina, Haiti, other
CARICOM countries, Dominican Republic, Costa Rica, Panama,
Afghanistan, Bangladesh, Pakistan, Philippines, Vietnam,
Indonesia, South Africa, Nigeria, Kenya, Ghana, Cabo Verde,
Egypt, Jordan, Iraq, Yemen, Tunisia, Oman, West Bank and Gaza,
Ukraine, Kosovo, Georgia, Moldova, and Bosnia.

(Reporting by Jeff Mason
Additional reporting by Trevor Hunnicutt and Nandita Bose
Editing by Chizu Nomiyama and Lisa Shumaker)

More News
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 07:43

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Read more
22 Sep 2023 08:42

LONDON MARKET OPEN: Stocks slip after central bank rate calls

(Alliance News) - Stock prices in London opened lower on Friday, but managed to avoid the steep declines seen in New York, as investors mulled over an eventful week dominated by central bank decisions.

Read more
22 Sep 2023 08:13

TOP NEWS: AstraZeneca's datopotamab deruxtecan shows positive results

(Alliance News) - AstraZeneca PLC on Friday said phase three data showed that datopotamab deruxtecan delivered improvement in progression-free survival in breast cancer patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.